RAFAEL KHAIM: Open Payments
NPI 1306048665 · NEW YORK, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$291 in 7 payments from 5 companies in 2025. Trend: 2023 $621 · 2024 $479 · 2025 $291
Food & beverage: $271Speaker / faculty: $20
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 1 | $125 |
| AstraZeneca Pharmaceuticals LP | 3 | $81 |
| Mallinckrodt Hospital Products Inc. | 1 | $34 |
| GENZYME CORPORATION | 1 | $30 |
| Becton, Dickinson and Company | 1 | $20 |
Products named: UBRELVY, FARXIGA, ACTHAR, DUPIXENT, LOKELMA, PowerGlide.
Industry payments across NY — which companies pay providers there.
